SCHEMBL5419675

SCHEMBL5419675

Cc1cc(C)c(C)c(C)c1C.Cc1ccc(S(=O)(=O)N[C@H]2CCCC[C@@H]2N)cc1.[Ru]

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
TSHR P16473 2/20 0.51
CYP3A4 P08684 1/20 0.51
MCOLN2 Q8IZK6 2/20 0.41
MCOLN3 Q8TDD5 2/20 0.41
MCOLN1 Q9GZU1 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
MMP13 P45452 2/20 0.40
MMP2 P08253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5411642 1.00 ALDH1A1 (0.51) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
SCHEMBL5418695 0.94 ALDH1A1 (0.52) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
SCHEMBL5433387 0.94 ALDH1A1 (0.52) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
SCHEMBL5415729 0.94 ALDH1A1 (0.55) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
SCHEMBL5426276 0.94 ALDH1A1 (0.55) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
Hexamethylbenzene SCHEMBL5424696 0.94 ALDH1A1 (0.57) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
Hexamethylbenzene SCHEMBL5423380 0.94 ALDH1A1 (0.57) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
SCHEMBL5424820 0.92 ALDH1A1 (0.54) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
SCHEMBL5426272 0.92 ALDH1A1 (0.54) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3
P-Xylene SCHEMBL5422459 0.91 ALDH1A1 (0.60) ALDH1A1TSHRCYP3A4MCOLN2MCOLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268250-B2 Process for producing optically active compound KANTO KAGAKU KABUSHIKI KAISHA (JP) 2007-09-11 US disclosed
US-20040176616-A1 Process for producing optically active compound KANTO KAGAKU KABUSHIKI KAISHA 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176616-A1 Process for producing optically active compound OSTC, NPEPPS, PPOX ALDH1A1 3566/4885TSHR 3616/4885CYP3A4 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.